Mereo BioPharma Group - - 53 Year Dividend History | MREO
Historical dividend payout and yield for Mereo BioPharma Group - (MREO) since 1971. The current TTM dividend payout for Mereo BioPharma Group - (MREO) as of November 20, 2024 is $0.00. The current dividend yield for Mereo BioPharma Group - as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.490B |
$0.010B |
|
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company's rare disease product candidates, setrusumab for the treatment of osteogenesis imperfecta and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease. Mereo BioPharma Group plc is based in LONDON.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
